Introduction: Salidroside (Sal) a bioactive component extracted from Rhodiola rosea is remarkable for its anti-asthmatic effects. The study aimed to explore the molecular mechanism of Sal in airway inflammation and remodeling in asthmatic mice and provide a novel theoretical basis for asthma treatment. Methods: An asthmatic mouse model was established via ovalbumin (OVA) treatment, followed by injection of Sal and transfection of miR-323-3p-mimic and sh- suppressor of cytokine signaling 5 (SOCS5). Expressions of miR-323-3p, SOCS5 mRNA, collagen (COL)-I, and COL-III were detected via reverse transcription quantitative polymerase chain reaction. SOCS5 protein level was detected via Western blot. Levels of IgE, IL-13, IL-4, and IL-5 were detected via enzyme-linked immunosorbent assay. Inflammatory cell infiltration was observed via hematoxylin-eosin staining. Collagen disposition was observed via Masson staining. Resistance index (RI) of airway hyperresponsiveness, and the number of total cells, inflammatory cells (eosinophil, macrophage, neutrophil, and lymphocyte) in bronchoalveolar lavage fluid (BALF) were observed. The binding relationship between miR-323-3p and SOCS5 was predicted through the RNA22 website and verified via dual-luciferase reporter assay. Results: miR-323-3p was highly expressed in OVA-treated mice. Sal treatment reduced inflammatory cell infiltration, COL disposition, miR-323-3p expression, and IgE, IL-13, IL-4, IL-5, COL-I, and COL-III levels, RI value, and the number of total cells and inflammatory cells in BALF. miR-323-3p inhibited SOCS5 transcription. miR-323-3p overexpression or SOCS5 downregulation reversed the protecting role of Sal in asthmatic mice. Conclusion: Sal inhibited miR-323-3p expression to promote SOCS5 transcription, thereby attenuating airway inflammation and remodeling in asthmatic mice.

Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma.
. 2018 Feb 24;391(10122):783–800.
Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment.
J Allergy Clin Immunol
. 2017 Feb;139(2):438–47.
Patel SJ, Teach SJ. Asthma.
Pediatr Rev
. 2019 Nov;40(11):549–67.
King-Biggs MB. Asthma.
Ann Intern Med
. 2019 Oct 1;171(7):ITC49–64.
Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine.
Clin Sci
. 2017 Jul 15;131(14):1723–35.
Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, et al. Revisiting type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
Clin Exp Allergy
. 2017 Feb;47(2):161–75.
Menzies-Gow A, McBrien CN, Baker JR, Donnelly LE, Cohen RT. Update in asthma and airway inflammation 2018.
Am J Respir Crit Care Med
. 2019 Jul 1;200(1):14–9.
Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma: what really matters.
Cell Tissue Res
. 2017 Mar;367(3):551–69.
Hough KP, Curtiss ML, Blain TJ, Liu RM, Trevor J, Deshane JS, et al. Airway remodeling in asthma.
Front Med
. 2020;7:191.
Brasier AR. Therapeutic targets for inflammation-mediated airway remodeling in chronic lung disease.
Expert Rev Respir Med
. 2018 Nov;12(11):931–9.
Li H, Yang T, Wu R, Chen T, Sun Z, Yang L. Salidroside inhibits platelet-derived growth factor-induced proliferation and migration of airway smooth muscle cells.
J Cell Biochem
. 2019 Apr;120(4):6642–50.
Cai H, Wang J, Mo Y, Ye L, Zhu G, Song X, et al. Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis.
Int Immunopharmacol
. 2020 Apr;81:106243.
van den Berge M, Tasena H. Role of micro-RNAs and exosomes in asthma.
Curr Opin Pulm Med
. 2019 Jan;25(1):87–93.
Qian C, Liang S, Wan G, Dong Y, Lu T, Yan P. Salidroside alleviates high-glucose-induced injury in retinal pigment epithelial cell line ARPE-19 by down-regulation of miR-138.
RNA Biol
. 2019 Oct;16(10):1461–70.
Zhang Y, Lin F, Yan Z, Chen Z, Chen Y, Zhao Y, et al. Salidroside downregulates micro-RNA133a and inhibits endothelial cell apoptosis induced by oxidized lowdensity lipoprotein.
Int J Mol Med
. 2020 Oct;46(4):1433–42.
Xu T, Li L, Huang C, Li X, Peng Y, Li J. MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer’s disease and ectopic pregnancy.
Expert Opin Ther Targets
. 2014 Feb;18(2):153–8.
Karner J, Wawrzyniak M, Tankov S, Runnel T, Aints A, Kisand K, et al. Increased micro-RNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in the regulation of the TGF-beta pathway and IL-22 production.
. 2017 Jan;72(1):55–65.
Gras D, Chanez P. New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
Eur Respir J
. 2016 Sep;48(3):608–10.
Liu J, Cheng Y, Zhang X, Zhang X, Chen S, Hu Z, et al. Astragalin attenuates allergic inflammation in a murine asthma model.
. 2015 Oct;38(5):2007–16.
Saltykova IV, Ogorodova LM, Bragina EY, Puzyrev VP, Freidin MB. Opisthorchis felineus liver fluke invasion is an environmental factor modifying genetic risk of atopic bronchial asthma.
Acta Trop
. 2014 Nov;139:53–6.
Jones-Bolin S. Guidelines for the care and use of laboratory animals in biomedical research.
Curr Protoc Pharmacol
. 2012 Dec.
Qin HB, Xu B, Mei JJ, Li D, Liu JJ, Zhao DY, et al. Inhibition of miRNA-221 suppresses the airway inflammation in asthma.
. 2012 Aug;35(4):1595–9.
Yan GH, Choi YH. Salidroside attenuates allergic airway inflammation through negative regulation of nuclear factor-kappa B and p38 mitogen-activated protein kinase.
J Pharmacol Sci
. 2014;126(2):126–35.
Tang XW, Qin QX. miR-335-5p induces insulin resistance and pancreatic islet β-cell secretion in gestational diabetes mellitus mice through VASH1-mediated TGF-β signaling pathway.
J Cell Physiol
. 2019 May;234(5):6654–66.
Plank MW, Maltby S, Tay HL, Stewart J, Eyers F, Hansbro PM, et al. MicroRNA expression is altered in an ovalbumin-induced asthma model and targeting mir-155 with antagomirs reveals cellular specificity.
PLoS One
. 2015;10(12):e0144810.
Banno A, Reddy AT, Lakshmi SP, Reddy RC. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma.
Clin Sci
. 2020 May 15;134(9):1063–79.
Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma.
. 2019 Apr 16;50(4):975–91.
Wu YG, Wang LX. Function of MMP/TIMP on airway remodeling of bronchial asthma and treating effects of Zhichuan capsule.
Zhong Xi Yi Jie He Xue Bao
. 2004 Nov;2(6):435–9.
Hu R, Wang MQ, Ni SH, Wang M, Liu LY, You HY, et al. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-kappaB/NLRP3 signaling pathway in AGEs-induced HUVECs.
Eur J Pharmacol
. 2020 Jan 15;867:172797.
Zheng L, Su J, Zhang Z, Jiang L, Wei J, Xu X, et al. Salidroside regulates inflammatory pathway of alveolar macrophages by influencing the secretion of miRNA-146a exosomes by lung epithelial cells.
Sci Rep
. 2020 Nov 27;10(1):20750.
Li R, Guo Y, Zhang Y, Zhang X, Zhu L, Yan T. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4/NF-κB and MAPK signaling pathways.
Int J Mol Sci
. 2019 Mar 4;20(5):1103.
Wang J, Jin RG, Xiao L, Wang QJ, Yan TH. Anti-asthma effects of synthetic salidroside through regulation of Th1/Th2 balance.
Chin J Nat Med
. 2014 Jul;12(7):500–4.
Cossellu G, Motta V, Dioni L, Angelici L, Vigna L, Farronato G, et al. Titanium and zirconium levels are associated with changes in microRNAs expression: results from a human cross-sectional study on obese population.
PLoS One
. 2016;11(9):e0161916.
Park J, Jeong S, Park K, Yang K, Shin S. Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury.
Exp Ther Med
. 2018 Jun;15(6):5495–502.
Zhang J, Lang Y, Guo L, Pei Y, Hao S, Liang Z, et al. MicroRNA-323a-3p promotes pressure overload-induced cardiac fibrosis by targeting TIMP3.
Cell Physiol Biochem
. 2018;50(6):2176–87.
Recio C, Oguiza A, Mallavia B, Lazaro I, Ortiz-Munoz G, Lopez-Franco O, et al. Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.
Basic Res Cardiol
. 2015 Mar;110(2):8.
Chen X, Rao SQ, Gao BH, Jiang ZQ. Effect of early vitamin D supplementation on asthma and the possible mechanisms.
Genet Mol Res
. 2015 Oct 30;14(4):14136–43.
Alharris E, Alghetaa H, Seth R, Chatterjee S, Singh NP, Nagarkatti M, et al. Resveratrol attenuates allergic asthma and associated inflammation in the lungs through regulation of miRNA-34a that targets foxP3 in mice.
Front Immunol
. 2018;9:2992.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.